MISSISSAUGA, ON, May 17, 2021 /CNW/ - Nuvo Pharmaceuticals Inc.
(TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the
Company) a Canadian focused healthcare company with global
reach and a diversified portfolio of commercial products, today
announced that at its 2021 Virtual Annual Meeting of
Shareholders held on May 17, 2021
(the Meeting), all nominees listed in the management proxy circular
dated April 9, 2021 were elected as
directors of the Company.
The detailed results of the votes by proxy and virtual votes
received at the Meeting are as follows:
|
DIRECTOR
NOMINEES
|
NUMBER OF SHARES
|
PERCENTAGE OF VOTES CAST
|
|
FOR
|
WITHHELD
|
FOR
|
WITHHELD
|
|
Daniel Chicoine
|
2,523,485
|
232,767
|
91.55%
|
8.45%
|
|
David A. Copeland
|
2,687,459
|
68,793
|
97.50%
|
2.50%
|
|
Anthony E. Dobranowski
|
2,652,757
|
103,495
|
96.25%
|
3.75%
|
|
Robert Harris
|
2,687,624
|
68,628
|
97.51%
|
2.49%
|
|
John C. London
|
2,528,050
|
228,202
|
91.72%
|
8.28%
|
|
Mary Ritchie
|
2,692,270
|
63,982
|
97.68%
|
2.32%
|
In addition, the Company reports that the appointment of Ernst
& Young LLP as the Company's auditors for the ensuing fiscal
year was passed by a majority of the votes represented at the
Meeting. The Company's full report of voting results on matters
presented at the Meeting can be found at www.sedar.com.
About Miravo Healthcare
Miravo is a
Canadian focused, healthcare company with global reach and a
diversified portfolio of commercial products. The Company's
products target several therapeutic areas, including pain, allergy,
neurology and dermatology. The Company's strategy is to
in-license and acquire growth-oriented, complementary products for
Canadian and international markets. Miravo's head office is
located in Mississauga, Ontario,
Canada, the international operations are located in
Dublin, Ireland and the Company's
manufacturing facility is located in Varennes, Québec, Canada. The
Varennes facility operates in a
Good Manufacturing Practices (GMP) environment respecting the U.S.,
Canada and E.U. GMP regulations
and is regularly inspected by Health Canada and the U.S. Food and
Drug Administration. For additional information, please visit
www.miravohealthcare.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-announces-director-election-results-of-its-annual-meeting-of-shareholders-301292844.html
SOURCE Nuvo Pharmaceuticals Inc.